In Lung stereotactic ablative radiotherapy (SABR), 4D PET-CT gives an edge over static 3D PET-CT in target volume delineation given its ability to reduce motion artifacts. Motion Freeze (MF) PET imaging combines the quantitative benefits of 100% counts of 4D phase-matched PET-CT imaging into a single static image by collecting CT & PET data at each phase of the breathing cycle, then matching the data for attenuation consistency. This provides further robustness of biologic target volume delineation with reduced image noise. The authors evaluated the utility of 4D PET-CT MF imaging in lung SABR treatments & the consequent dosimetric impact when either motion inclusive (retrospective imaging) technique or gating technique were to be used. Five patients of lung SABR were included for purpose of this dosimetric study (1 Ca lung and 4 lung oligo-metastasis). All patients underwent 4D CT /PET scan with the RPM system on 16 slice PET-CT scanner. The 4D CT and 4D PET data were binned in 10 phases of respiratory cycle. The Motion match software was utilized to create a MF image of all the 10 PET bins (MF-10) and 3 bins corresponding to end expiratory phase 40%,50%,60% (MF-3) in which tumor position was relatively stable. For study purpose we analyzed 3 clinical scenarios for target delineation (a) target volume generated using 4D CT alone (b) 4D CT all bins deformably registered with MF-10 (c) 4D-CT 3 bins deformably registered with corresponding MF-3, using gradient based intensity based registration algorithm. Three VMAT 6 MV FFF plans were generated for all the above all 3 volumes. The dosimetric parameters analysed included Target volume coverage, dose spillage (high, intermediate and low dose) & OAR doses as per RTOG protocol. Statistical comparison was done using paired sample t test in statistical analysis software. The target volume was reduced using 4D PET MF 10 & MF 3 as compared to 4D CT alone though the values were statistically insignificant [P=0.75(MF10), P=0.68 (MF3)]. There was statistically insignificant difference in target volume coverage parameters i.e. Conformity index, Heterogeneity index, dose spillage (high, intermediate and low dose) among all the plans. However the trend towards reduced OAR doses was seen in MF 10 plan & MF 3 plan as compared to 4D CT plan {Lungs V20 [P=0.06(MF10), P=0.08(MF3)], Heart Dmax [P=0.02(MF10), P=0.03(MF3)], Spinal cord Dmax [P=0.08(MF10), P=0.07(MF3)], Chest wall Dmax [P=0.001(MF10), P=0.037(MF3)], Great Vessel Dmax [P=0.03(MF10), P=0.045 (MF3)]}. Inclusion of 4D PET-CT MF scan 10 bins (non gated delivery) or 3 bins (gated delivery) can improvise the robustness of Lung SABR in terms of better target volume delineation, OAR doses & estimation of SUV values helping in better treatment response evaluation in follow up. While this study, first of its kind for Lung SABR, gives proof-of-concept & integration into workflow, a larger sample size evaluating 4D PET-CT MF would address the target delineation issue.
Read full abstract